WEBVTT

00:00:00.040 --> 00:00:03.520
It's really around reaching the right
people at the right time with the right message.

00:00:05.200 --> 00:00:07.720
We're joined by Maya from Outcomes4Me,

00:00:07.720 --> 00:00:08.480
Welcome.

00:00:08.760 --> 00:00:09.720
Thank you for having me.

00:00:09.800 --> 00:00:12.800
Maya,
you've just completed a new funding round.

00:00:13.000 --> 00:00:16.320
What's fueling the growth,
and what are the opportunities that you

00:00:16.320 --> 00:00:16.560
see?

00:00:16.960 --> 00:00:18.080
Yeah, thank you for asking.

00:00:18.080 --> 00:00:23.040
So we just concluded $20 million round,
which brings our total funding to $38

00:00:23.040 --> 00:00:23.560
million.

00:00:23.960 --> 00:00:27.040
And just what we are is a
patient-empowerment platform.

00:00:27.040 --> 00:00:31.080
So it's helping people diagnosed with
life-altering chronic diseases,

00:00:31.080 --> 00:00:35.960
help them manage through their lives from
diagnosis or suspicious of the diagnosis,

00:00:35.960 --> 00:00:37.120
for the entire life.

00:00:37.120 --> 00:00:41.160
So what's filling the growth is,
we started first in breast cancer,

00:00:41.160 --> 00:00:45.520
and really we were able to really
fundamentally help people take action,

00:00:45.520 --> 00:00:49.480
advocate for themselves,
and have them get to the best treatment.

00:00:49.680 --> 00:00:51.800
We expanded across multiple cancers.

00:00:51.800 --> 00:00:55.680
And now with this growth round,
we're looking to go international.

00:00:55.680 --> 00:00:58.320
We just announced an acquisition in
Germany,

00:00:58.320 --> 00:01:01.240
and we're looking to also add more of,
you know,

00:01:01.240 --> 00:01:04.000
helping patients navigate through their
care.

00:01:04.560 --> 00:01:09.680
And how do you build trust and scale
adoption in such a high-stakes world as

00:01:09.680 --> 00:01:10.480
cancer care?

00:01:10.520 --> 00:01:10.880
Yeah.

00:01:10.880 --> 00:01:14.200
So one thing that's very tricky is when
you're dealing with people,

00:01:14.200 --> 00:01:15.440
vulnerable people, right?

00:01:15.440 --> 00:01:19.520
When somebody's diagnosed with cancer,
their life changes overnight,

00:01:19.520 --> 00:01:21.200
and so they feel vulnerable.

00:01:21.200 --> 00:01:25.720
So what's really important is first to
build trust.

00:01:25.720 --> 00:01:29.760
So trust comes with two main components,
transparency.

00:01:30.000 --> 00:01:34.960
So really being transparent about who you
are, what you do, and how you grow,

00:01:34.960 --> 00:01:36.960
and how you grow as a platform.

00:01:37.320 --> 00:01:41.120
And two, being science,
evidence based so that the information

00:01:41.120 --> 00:01:44.360
you provide to people is trustworthy,
is actionable,

00:01:44.360 --> 00:01:49.280
and then it's also needs to be relevant
to people so that they can really use it

00:01:49.280 --> 00:01:52.840
in a way that helps them and continues to
fuel the trust.

00:01:53.280 --> 00:01:56.440
Looking ahead,
how do you see tech and AI-driven

00:01:56.440 --> 00:02:01.400
patient-centered platforms changing the
relationship between patients in the

00:02:01.400 --> 00:02:02.640
health care system?

00:02:02.920 --> 00:02:04.200
Yeah, that's a great question.

00:02:04.200 --> 00:02:09.920
I mean, up to very recently,
tech has not fundamentally helped people

00:02:09.920 --> 00:02:16.680
in the same—patients in the same way it
has helped us in all other aspects of our

00:02:16.680 --> 00:02:17.200
lives.

00:02:17.200 --> 00:02:22.600
And one of the reasons for that is
everything that has been conceived from a

00:02:22.600 --> 00:02:26.600
health system perspective is not really
consumer driven.

00:02:26.600 --> 00:02:29.840
And we're ultimately first people before
becoming patients.

00:02:30.240 --> 00:02:33.080
So now with AI, you know,
there's—first of all,

00:02:33.080 --> 00:02:35.760
people are taking things in their own
hands.

00:02:36.000 --> 00:02:39.280
So they're using ChatGPT, etcetera,
to try to help them navigate through

00:02:39.280 --> 00:02:39.800
their care.

00:02:40.080 --> 00:02:44.800
Now that's both an opportunity but also
it has limitations because there's only

00:02:44.800 --> 00:02:49.280
so much you could do without really the
data-driven evidence to really help

00:02:49.280 --> 00:02:51.080
people in a very specific way.

00:02:51.080 --> 00:02:53.920
So this is where tech platforms,
like ours,

00:02:53.920 --> 00:02:58.960
that leverage AI in a very specific
manner that's very actionable to people,

00:02:58.960 --> 00:03:03.600
could fundamentally not only transform
care but also improve outcomes.

00:03:04.560 --> 00:03:08.600
And what you've created is a free
direct-to-patient platform.

00:03:08.840 --> 00:03:10.760
Just explain how have you managed to make
that work?

00:03:10.760 --> 00:03:13.600
How have you managed to make it a win,
win, win for both the patients,

00:03:13.600 --> 00:03:15.240
the providers, and the pharma companies?

00:03:15.360 --> 00:03:15.600
Yeah.

00:03:15.600 --> 00:03:19.840
So I come from a pharma background.
You know, I was at BCG, and then I spent,

00:03:19.840 --> 00:03:21.480
you know, my career in pharma.

00:03:21.760 --> 00:03:25.880
And the reason I started the company is
because I saw really the innovation

00:03:25.880 --> 00:03:28.120
opportunity coming from pharma in cancer.

00:03:28.360 --> 00:03:30.640
I do sincerely believe that in my
lifetime,

00:03:30.640 --> 00:03:32.640
we're going to control or cure cancer.

00:03:32.920 --> 00:03:35.920
But at the same time,
that's not getting fast enough to

00:03:35.920 --> 00:03:38.680
patients. And people are really having,
struggling,

00:03:38.680 --> 00:03:42.200
navigating through their care once they
have a cancer diagnosis.

00:03:42.200 --> 00:03:46.880
So this is where there's real opportunity
to fundamentally help people by

00:03:46.880 --> 00:03:51.280
connecting them to the right treatment
and helping them take action.

00:03:51.280 --> 00:03:55.600
So this is where the win-win comes in.
Where first we're free to patients

00:03:55.600 --> 00:03:59.440
because we want everybody,
wherever they are, whomever they are,

00:03:59.440 --> 00:04:03.560
to be able to have the same care or
access to care that they deserve.

00:04:04.000 --> 00:04:06.960
And we partner with pharma,
which we're here at Cannes Lions,

00:04:06.960 --> 00:04:10.760
where it's really around reaching the
right people at the right time with the

00:04:10.760 --> 00:04:11.440
right message.

00:04:11.680 --> 00:04:16.360
So that's part of our business model to
really help activate people,

00:04:16.360 --> 00:04:18.480
get them the right information,

00:04:18.640 --> 00:04:21.640
and that's how we scale things with our
pharma partners.

00:04:21.880 --> 00:04:24.080
And so it's a win-win.
A win for the patients,

00:04:24.080 --> 00:04:26.480
a win for the pharma,
and ultimately a win for us.

00:04:26.480 --> 00:04:28.520
It helps us continue to scale the
platform.

00:04:28.640 --> 00:04:30.320
Yeah, it's a huge success.

00:04:30.520 --> 00:04:32.560
Well, Maya,
thanks very much for joining us here.

00:04:32.560 --> 00:04:33.520
Thank you so much.

00:04:33.520 --> 00:04:34.600
Thank you for having me.